ATEA PHARMACEUTICALS, INC.

Lobbying Spend

—

Filings

Firms Hired

Active Period

2020–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	3	1
2024	—	3	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE CONAFAY GROUP, LLC	—	19
JEFFREY J. KIMBELL & ASSOCIATES, INC.	—	6

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	16
SENATE	16
Health & Human Services, Dept of (HHS)	13

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	18
Budget/Appropriations	Budget/Appropriations	17
Health Issues	Health Issues	7

ATEA PHARMACEUTICALS, INC. — Lobbying Disclosure | Poliscope